Taysha Gene Therapies
Price & Volume
Stats
See moreOpen | $5.80 |
Previous Close | $5.91 |
Day Range | $5.72-$5.80 |
52W Range | $1.05-$6.02 |
Market Cap | $1.6B |
Shares Short | 48M |
Financials
See moreRevenue (12 Mos) | $6.3M |
Revenue Growth (YoY) | 78.6% |
Gross Profit (12 Mos) | $6.3M |
Diluted EPS | -$0.33 |
News
See moreYahoo Finance • 21 days ago
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Is Taysha Gene Therapies Inc. (TSHA) One of the Must-Buy Penny Stocks to Buy Now?
Yahoo Finance • 2 months ago
Taysha outlines accelerated BLA timeline for TSHA-102 with FDA Breakthrough Therapy designation and full global rights
Yahoo Finance • 2 months ago
Taysha Gene Therapies regains full rights to TSHA-102
About
CEO | Mr. Sean P. Nolan |
CFO | Mr. Kamran Alam CPA, M.B.A. |
Address | 3000 Pegasus Park Drive, Dallas, TX, United States, 75247 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |
